Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-09

FDA Approved: MUCUS RELIEF — Supplemental Application (CHAIN DRUG MARKETING ASSOCIATION, INC.)

View source ↗

Summary

FDA approved a supplemental application for MUCUS RELIEF, an over-the-counter guaifenesin product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MUCUS RELIEF (guaifenesin)

Snippet

SUPPL AP for MUCUS RELIEF (GUAIFENESIN)